Hennion & Walsh Asset Management Inc. lifted its position in Stryker Co. (NYSE:SYK – Free Report) by 74.7% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,915 shares of the medical technology company’s stock after buying an additional 2,102 shares during the period. Hennion & Walsh Asset Management Inc.’s holdings in Stryker were worth $1,759,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of the company. Burkett Financial Services LLC purchased a new position in Stryker in the fourth quarter worth $25,000. Farmers & Merchants Trust Co of Chambersburg PA grew its stake in Stryker by 203.3% during the 4th quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 91 shares of the medical technology company’s stock worth $27,000 after buying an additional 61 shares during the last quarter. Rogco LP acquired a new position in Stryker during the 4th quarter valued at about $30,000. DSM Capital Partners LLC purchased a new stake in Stryker in the fourth quarter valued at about $34,000. Finally, HBC Financial Services PLLC purchased a new stake in Stryker in the fourth quarter valued at about $37,000. Institutional investors own 77.09% of the company’s stock.
Stryker Stock Up 0.1 %
SYK stock opened at $340.25 on Friday. Stryker Co. has a 52 week low of $249.98 and a 52 week high of $361.41. The company has a quick ratio of 0.99, a current ratio of 1.71 and a debt-to-equity ratio of 0.56. The firm has a 50-day simple moving average of $337.38 and a 200-day simple moving average of $333.66. The stock has a market capitalization of $129.62 billion, a P/E ratio of 38.84, a P/E/G ratio of 2.68 and a beta of 0.92.
Stryker Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Friday, June 28th will be issued a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a dividend yield of 0.94%. The ex-dividend date is Friday, June 28th. Stryker’s payout ratio is 36.53%.
Analyst Ratings Changes
Several research firms have recently issued reports on SYK. Wells Fargo & Company upped their price objective on shares of Stryker from $364.00 to $381.00 and gave the company an “overweight” rating in a report on Wednesday, May 1st. StockNews.com raised shares of Stryker from a “hold” rating to a “buy” rating in a report on Tuesday, June 25th. TD Cowen boosted their price objective on shares of Stryker from $365.00 to $400.00 and gave the company a “buy” rating in a report on Thursday, April 11th. BTIG Research upped their target price on Stryker from $366.00 to $369.00 and gave the company a “buy” rating in a research report on Wednesday, May 1st. Finally, Evercore ISI boosted their price target on Stryker from $340.00 to $370.00 and gave the company an “outperform” rating in a research note on Thursday, April 4th. Four investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $370.58.
Stryker Company Profile
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
See Also
- Five stocks we like better than Stryker
- Insider Trading – What You Need to Know
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- 3 Stocks to Consider Buying in October
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Investing in Construction Stocks
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.